Found 4370 articles for: ""
Ensuring Dermatologists Practice Enhanced Antibiotic Stewardship With Sarecycline Mnemonic
October 2023 | Volume 22 | Issue 10 | Editorials | 1061 | Copyright © October 2023
It must be ensured that dermatologists practice enhanced antibiotic stewardship to combat antimicrobial resistance and negative consequences of microbiome dysbiosis. In order to help achieve this, we ...
Read MoreParticipant Satisfaction of a Community-based Telehealth Clinic for Atopic Dermatitis
October 2023 | Volume 22 | Issue 10 | Editorials | 1066 | Copyright © October 2023
Atopic dermatitis (AD), a chronic, relapsing inflammatory disease that affects more than 30 million children and adults in the US, disproportionally impacts African American (AA) and Hispanic children...
Read MoreOnychomycosis Treatment Prescribed at Only Twenty Percent of Visits: A Cross-Sectional Analysis of the National Ambulatory Medical Care Survey 2007 to 2016
October 2023 | Volume 22 | Issue 10 | Original Article | 1040 | Copyright © October 2023
Background: Onychomycosis represents the highest proportion of nail disorders seen in clinical practice. Onychomycosis management may differ amongst specialties, with impact on patien...
Read MoreKeratosis Pilaris: Treatment Practices of Board-Certified Dermatologists
October 2023 | Volume 22 | Issue 10 | Original Article | 985 | Copyright © October 2023
Keratosis pilaris (KP) is a chronic disorder of follicular hyperkeratinization and perifollicular erythema with lesions affecting the extensor surfaces of arms, upper legs, and buttocks. While there i...
Read MoreUpdates in the Treatment of Body-Focused Repetitive Disorders
October 2023 | Volume 22 | Issue 10 | Features | 1069 | Copyright © October 2023
Body-focused repetitive disorders (BFRBs) are psychocutaneous disorders that are underrecognized and undertreated....
Read MoreTopical Ivermectin Is Associated With Improved Erythematotelangiectatic, Papulopustular, and Phymatous Rosacea in a Secondary Analysis
October 2023 | Volume 22 | Issue 10 | Editorials | 1063 | Copyright © October 2023
Rosacea has variable clinical presentation consisting of four overlapping phenotypes: erythematotelangiectatic, papulopustular, phymatous, and ocular.1 Rosacea's pathogenesis involves incre...
Read MoreUnexpected Clinical Lessons Learned From IL-4 and IL-13 Blockade
October 2023 | Volume 22 | Issue 10 | Editorials | 1007 | Copyright © October 2023
In 2017, dupilumab became the first FDA approved systemic therapy for atopic dermatitis. Since its approval, extensive clinical experience and continued research have revealed a number of unexpected e...
Read MoreMechanism of Action of Brodalumab May Correlate With Efficacy in Patients With Inflammatory Skin Diseases
October 2023 | Volume 22 | Issue 10 | Original Article | 994 | Copyright © October 2023
Biologic therapy is used for systemic treatment of multiple inflammatory conditions, including moderate-to-severe plaque psoriasis. Brodalumab is an interleukin-17 (IL-17) receptor A antagonist indica...
Read MoreAnt Venom-Based Ceramide Therapy Is Effective Against Atopic Dermatitis In Vivo
October 2023 | Volume 22 | Issue 10 | Original Article | 1001 | Copyright © October 2023
Background: Atopic dermatitis (AD) is a common skin condition with relatively few therapeutic alternatives. These include corticosteroids, which address inflammation but not superinfe...
Read MoreThe Psychosocial Burden of Skin Disease and Dermatology Care Insights Among Skin of Color Consumers
October 2023 | Volume 22 | Issue 10 | Original Article | 1027 | Copyright © October 2023
Background: Skin conditions are associated with psychological symptoms and may be particularly distressing for skin of color (SoC) individuals. SoC consumers' decisions to pursue derm...
Read MoreAlopecia Areata: The Clinician and Patient Voice
October 2023 | Volume 22 | Issue 10 | Original Article | 967 | Copyright © October 2023
Alopecia areata (AA), an autoimmune disorder of hair follicles, results in varying degrees of scalp, facial, and body hair loss. In addition, it is associated with profound psychosocial and quali...
Read MoreA Review of the Efficacy of Topical Statins for Treating Disseminated Superficial Actinic Porokeratosis
October 2023 | Volume 22 | Issue 10 | Original Article | 1053 | Copyright © October 2023
Porokeratosis is a rare group of acquired or hereditary dermatoses characterized by linear or annular plaques with a keratotic border. DSAP is the most common porokeratosis, and lesions range fro...
Read MoreComparing the Efficacy for Pulse Versus Continuous Dose Terbinafine Therapy in Patients With Onychomycosis
October 2023 | Volume 22 | Issue 10 | Original Article | 1017 | Copyright © October 2023
Recently, treatment outcomes in patients with toenail onychomycosis have improved considerably due to more effective oral antifungal medications such as terbinafine and itraconazole. These medica...
Read MoreFULL SUPPLEMENT: Optimizing Transungal Efficacy at the Site of the Infection With Efinaconazole
September 2023 | Volume 22 | Issue 9 | Department | SF378719s5 | Copyright © September 2023
Onychomycosis is a prevalent condition affecting the United States and global population. Treatment options are limited, with only 3 topical anti-fungal medications garnering approval in the US w...
Read MoreINDIVIDUAL ARTICLE: Real-World Evidence on the Use of Calcipotriene and Betamethasone Dipropionate Aerosol Foam 0.005%/0.064% in the Treatment of Psoriasis: A Review of Investigator-Initiated Studies Around the Globe
September 2023 | Volume 22 | Issue 9 | Department | SF378719s5 | Copyright © September 2023
Topical medications are commonly used to manage mild-to-moderate psoriasis and serve as adjunct therapies used in combination with phototherapy and systemic treatments. Fixed-dose calcipotriene (Cal) ...
Read MoreFractional Laser for Prevention of Non-melanoma Skin Cancer
September 2023 | Volume 22 | Issue 9 | Features | 953 | Copyright © September 2023
Citation: McCormick ET, Desai S, Nelson K, et al. Fractional laser for prevention of non-melanoma skin cancer. J Drugs Dermatol. 2023;22(9):953-954. doi:10.36849/JDD.2023.NVRN0923...
Read MoreTopical Treatments for Photoaged Skin
September 2023 | Volume 22 | Issue 9 | Original Article | 867 | Copyright © September 2023
Background: Photoaging due to cumulative lifetime ultraviolet light exposure is the greatest contributing factor to facial aging. With the continued growth of the population of i...
Read MoreINDIVIDUAL ARTICLE: Vehicles Matter
September 2023 | Volume 22 | Issue 9 | Supplement Individual Articles | s5 | Copyright © September 2023
Topical medications are commonly used to manage mild-to-moderate psoriasis and serve as adjunct therapies used in combination with phototherapy and systemic treatments. Fixed-dose calcipotriene (Cal) ...
Read MoreComparison of Physicochemical Characteristics and Biostimulatory Functions in Two Calcium Hydroxyapatite-Based Dermal Fillers
September 2023 | Volume 22 | Issue 9 | Original Article | 910 | Copyright © September 2023
Background: Dermal fillers containing calcium hydroxyapatite (CaHA) are categorized as biostimulatory. However, differences in CaHA biomaterial likely affect the resultant ...
Read MoreIndividual Article: Updated Review of Topical Pharmaceuticals and Complementary and Alternative Medications for the Treatment of Onychomycosis in Both General and Special Populations in the United States
September 2023 | Volume 22 | Issue 9 | Supplement Individual Articles | SF378719 | Copyright © September 2023
Media and other results for: ""